Show simple item record

dc.contributor.authorHowell, Sacha J
dc.contributor.authorCampone, M
dc.contributor.authorCortes, J
dc.contributor.authorDuhoux, FP
dc.contributor.authorRoss, S
dc.contributor.authorMorris, T
dc.contributor.authorFranklin, S
dc.date.accessioned2019-12-09T17:23:34Z
dc.date.available2019-12-09T17:23:34Z
dc.date.issued2019en
dc.identifier.citationHowell SJ, Campone M, Cortés J, Duhoux FP, Ross S, Morris T, et al. 341P Final results of the STEM trial: SFX-01 in the treatment and evaluation of ER+ Her2- metastatic breast cancer (mBC). Annals of Oncology. 2019;30(Supplement_5).en
dc.identifier.doi10.1093/annonc/mdz242.036en
dc.identifier.urihttp://hdl.handle.net/10541/622613
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz242.036en
dc.titleFinal results of the STEM trial: SFX-01 in the treatment and evaluation of ER+Her2-metastatic breast cancer (mBC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDivision of Cancer Sciences, The University of Manchester, Manchester, UKen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2020-01-22T20:10:32Z


Files in this item

Thumbnail
Name:
mdz242.036.pdf
Size:
82.44Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract

This item appears in the following Collection(s)

Show simple item record